Zeta Capital (H.K.) Ltd.(SFC:BGP562) was founded in 2015 in Hong Kong. It holds Type 9 (asset management) and Type 4 (advising on securities investment) licenses issued by HK Securities and Futures Commission. Zeta leverages on the trend of China's cross-border investment and financial service, provides investors and partners with financial solutions such as establishment of offshore funds, capital matching and fund operations. Zeta has invested in a broad range of unicorn projects including One Connect Pingan, WeDoctor, Akeso Biopharma, Sirnaomics, Apollomics, XtalPi,etc.

Why work with us

We provide one-stop service so you can focus on your investment decision-making while leaving everything else to us to handle for you.